BrooksCL, MorozA. Murine monoclonal antibodies: 49 years of experience—Is it a spent technique? Monoclon Antib Immunodiagn Immunother, 2024; 43(6):145–146; doi: 10.1089/mab.2024.0030
2.
LonbergN. Human antibodies from transgenic animals. Nat Biotechnol, 2005; 23(9):1117–1125; doi: 10.1038/nbt1135
3.
BanikSSR, KushnirN, DoranzBJ, et al.Breaking barriers in antibody discovery: Harnessing divergent species for accessing difficult and conserved drug targets. MAbs, 2023; 15(1):2273018; doi: 10.1080/19420862.2023.2273018
4.
AlmagroJC, Pedraza-EscalonaM, ArrietaHI, et al.Phage display libraries for antibody therapeutic discovery and development. Antibodies (Basel), 2019; 8(3):44; doi: 10.3390/antib8030044
5.
BennettNR, WatsonJL, RagotteRJ, et al.Atomically accurate de novo design of single-domain antibodies. bioRxiv, 2024; doi: 10.1101/2024.03.14.585103
6.
BennettNR, WatsonJL, RagotteRJ, et al.Atomically accurate de novo design of antibodies with RFdiffusion. bioRxiv, 2025; doi: 10.1101/2024.03.14.585103
7.
BioN, BiswasS. De novo design of epitope-specific antibodies against soluble and multipass membrane proteins with high specificity, developability, and function. bioRxiv, 2025; doi: 10.1101/2025.01.21.633066
8.
BioN, BiswasS. De novo design of hundreds of functional GPCR-targeting antibodies enabled by scaling test-time compute. bioRxiv, 2025; doi: 10.1101/2025.05.28.656709
